Logotype for SBI Life Insurance Company Limited

SBI Life Insurance Company (SBILIFE) Q3 24/25 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for SBI Life Insurance Company Limited

Q3 24/25 earnings summary

10 Jan, 2026

Executive summary

  • Achieved strong growth in new and renewal premiums, with December new business premium among the highest ever collected.

  • Maintained private market leadership with a 22.4% share in new business premium and 27.8% in individual new business premium.

  • 98.7% of individual applications submitted digitally; 99.3% death claim settlement ratio.

  • Embedded value as of December 31, 2024, stood at ₹681.4 billion, with new business value for the nine months at ₹42.9 billion, both independently reviewed and validated.

  • 1,086 offices and diverse distribution channels; 42.9bn value of new business generated as of Dec 2024.

Financial highlights

  • Gross written premium for 9M FY25 at ₹609.8bn, up 9% year-over-year; 5-year CAGR of 16%.

  • Profit after tax for 9M FY25 at ₹16.0bn, up 48% year-over-year; 5-year CAGR of 12%.

  • Value of new business at ₹42.9bn with a margin of 26.9%, up 6% year-over-year.

  • Assets Under Management reached ₹4.42 trillion, a 19% year-over-year increase.

  • Net premium earned for 9M FY25 at ₹602.0bn; investment income at ₹336.6bn.

Outlook and guidance

  • Individual APE growth expected at 15%-17% for the medium term; VNB margin to be maintained in the 27%-29% range.

  • For FY25, individual APE growth guided at 14%-15%, total APE at 10%-11%.

  • Positioned for continued double-digit growth in new business premium and renewals, leveraging digital and distribution strengths.

  • VNB growth may be slightly lower than APE growth due to product mix and margin rationalization.

  • The impact of the Sahara India Life Insurance business transfer is pending regulatory and legal resolution, with a hearing scheduled for February 2025.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more